stock listing
BioCardia Regains Compliance With Nasdaq Listing Requirement
The firm, in the midst of a Phase III trial testing a cell therapy for heart failure, has demonstrated compliance with Nasdaq's equity rule.
Allarity Therapeutics Lists on US Nasdaq Stock Market
The firm, previously based in Denmark, has closed its recapitalization share exchange and listed over 8 million shares of common stock on the Nasdaq.